Alnylam Pharmaceuticals, Inc. (ALNY) Stock Price Today
Aura AI Summary
Key Stats
- $29.48BMarket Cap
- -Volume
- HealthSector
- $491.2252W High
- $205.4852W Low
- -Typical Hold Time
- $27.44BEnterprise Value
- -Div Yield
- -Trading Activity
Track Alnylam Pharmaceuticals, Inc. (ALNY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Alnylam Pharmaceuticals, Inc. has traded between a low of $205.48 and a high of $491.22, highlighting its annual price range. Buy and sell Alnylam Pharmaceuticals, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Most Recent News
Rocket Lab wins $397M contract to build and launch Flatellites for US Space Force tracking program
Rocket Lab has secured a $397 million contract from the U.S. Space Force to develop, launch, and operate advanced Flatellites under the Space-Based Airborne Moving Target Indicator (SB-AMTI) program. This initiative aims to enhance real-time airborne...

Bunge Global SA gains insider buy and analyst boost, with price target up 28%
Bunge Global SA saw a director purchase 1,500 shares at $107.60, signaling insider confidence. Analysts have set a mean price target of $138.30, implying a 28.3% upside, driven by strong Q2 performance in soybeans and softseeds that raised earnings o...

Stocks plunge amid inverse ETF drops, legal probes, and earnings worries.
Stocks fell sharply due to various factors including a 58.71% drop in the Defiance Daily Target 2x Short PLTR ETF, driven by strong gains in Palantir Technologies, which the ETF inversely tracks. AdaptHealth shares dropped 38.09% amid a legal investi...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.